20260527.0001v1MethodReleased: May 19, 2026

Accelerating scientific discovery with Co-Scientist

Juraj Gottweis|Wei-Hung Weng|Alexander Daryin|Tao Tu|Petar Sirkovic|Artiom Myaskovsky|Grzegorz Glowaty|Felix Weissenberger|Alessio Orlandi|Dan Popovici|Anil Palepu|Keran Rong|Ryutaro Tanno|Khaled Saab|Fan Zhang|Jacob Blum|Andrew Carroll|Kavita Kulkarni|Nenad Tomašev|Dina Zverinski|Ivor Rendulic|Elahe Vedadi|Florian Hasler|Luka Rimanic|Marina Boia|Ivan Budiselic|Ben Feinstein|Mathias Bellaiche|Tom Sheffer|Jan Freyberg|Jeremy Ratcliff|Ottavia Bertolli|Katherine Chou|Avinatan Hassidim|Burak Gokturk|Amin Vahdat|Yuan Guan|Vikram Dhillon|Eeshit Dhaval Vaishnav|Byron Lee|Tiago R. D. Costa|José R. Penadés|Gary Peltz|Yossi Matias|James Manyika|Demis Hassabis|Yunhan Xu|Pushmeet Kohli|Annalisa Pawlosky|Alan Karthikesalingam|Vivek Natarajan

Abstract

Scientific discovery is driven by scientists generating novel hypotheses for complex problems that undergo rigorous experimental validation. To augment this process, we introduce Co-Scientist, a multi-agent AI system built on Gemini for structured scientific thinking and hypothesis generation. Co-Scientist aims to help scientists discover new original knowledge. Conditioned on their research objectives and prior scientific evidence, it formulates demonstrably novel research hypotheses for experimental verification. The system’s design involves agents continuously generating, critiquing and refining hypotheses accelerated by scaling test-time compute. Key contributions include: (1) a multi-agent architecture with an asynchronous task execution framework for flexible compute scaling; (2) a tournament evolution process for self-improving hypotheses generation. Automated evaluations show continued benefits of test-time compute scaling, improving hypothesis quality over time. While general purpose, we focus the validation in three biomedical applications: drug repurposing, novel target discovery 1, and explaining mechanisms of anti-microbial resistance 2. Specifically, Co-Scientist helped identify new drug repurposing candidates and synergistic combination therapies for acute myeloid leukemia, which were validated through in vitro experiments. These real-world validations demonstrate the potential of Co-Scientist to accelerate scientific discovery and usher in an era of AI empowered scientists.

Keywords

Co-Scientistmulti-agent AIscientific discoveryhypothesis generationtest-time compute scalingGeminiAI for Sciencedrug repurposingAMLscientific reasoningiterative refinementautonomous researchbiomedical AIhypothesis evolutionmulti-agent systems

External Source

This is an externally sourced paper. It was originally published independently.